Oncology Xagena
Aggiornamento in Medicina
AstraZeneca announced today that it has withdrawn the regulatory submissions for the use of ZACTIMA ( Vandetanib ) 100mg in combination with chemotherapy in patients with advanced non-small cell lung ...